GlassScriptPhysician profile
Sachin Chaudhary
NPI 1639341266
$90,031.83
in general payments reported to CMS, 2019-2025
10 companies · $5,794 in 2025
The $5,794 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $12K · 2021: $16K · 2022: $6,381 · 2023: $8,579 · 2024: $9,787 · 2025: $5,794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $1,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,170.00 |
| Food and Beverage | $1,989.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $75,086.49 | 2019-2025 | Ofev, Jascayd |
| Genentech USA, INC. | $14,508.72 | 2019-2022 | |
| United Therapeutics Corporation | $362.68 | 2021-2025 | Tyvaso, Tyvaso |
| La Jolla Pharmaceutical Company | $28.08 | 2024 | Giapreza |
| Amgen INC. | $27.28 | 2024 | Tavneos |
| Genentech, INC. | $18.58 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Chaudhary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.